郑州微飒生物科技有限责任公司 咨询热线：0371-88821766
行业动态

行业动态

追踪行业前沿，洞察产业趋势

药效评价Molecular and conformational determinants of pituitary adenylate cyclase-activating polypeptide (PACAP) for activation of the PAC1 receptor.

期刊：Journal of medicinal chemistry发表年份：2009作者：Steve Bourgault; David Vaudry; Isabelle Ségalas-Milazzo; Laure Guilhaudis; Alain Couvineau; Marc Laburthe; Hubert Vaudry; Alain Fournier
阅读更多 →

药效评价SB265610 is an allosteric, inverse agonist at the human CXCR2 receptor.

期刊：British journal of pharmacology发表年份：2009作者：M E Bradley; M E Bond; J Manini; Z Brown; S J Charlton
阅读更多 →

药效评价Pharmacokinetic and pharmacodynamic modeling of a monoclonal antibody antagonist of glucagon receptor in male ob/ob mice.

期刊：The AAPS journal发表年份：2009作者：Yvonne Y Lau; Peiming Ma; Leonid Gibiansky; Renee Komorowski; Jin Wang; George Wang; Hai Yan; Murielle M Véniant; Tarundeep Kakkar
阅读更多 →

药效评价Nonsteroidal anti-inflammatory drugs and ectodomain shedding of the amyloid precursor protein.

期刊：Neuro-degenerative diseases发表年份：2009作者：Stefanie Leuchtenberger; Juan Maler; Eva Czirr; Julia Ness; Stefan F Lichtenthaler; Hermann Esselmann; Claus U Pietrzik; Jens Wiltfang; Sascha Weggen
阅读更多 →